CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 

Wright Current Income Fund - 25th anniversary

 
 
 
 
 
 
Cipla Ltd Company Snapshot
Cipla Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cipla Ltd with three other companies in this sector in India: Ranbaxy Laboratories Limited (2014 sales of 104.24 billion Indian Rupees [US$1.68 billion] of which 125% was Pharmaceuticals), Aurobindo Pharma Ltd (81.00 billion Indian Rupees [US$1.31 billion] of which 100% was Pharmaceuticals), and Cadila Healthcare Ltd (72.24 billion Indian Rupees [US$1.17 billion] of which 100% was ).

Sales Analysis. Cipla Ltd reported sales of 101.00 billion Indian Rupees (US$1.63 billion) for the fiscal year ending March of 2014. This represents an increase of 22.9% versus 2013, when the company's sales were 82.16 billion Indian Rupees. Sales at Cipla Ltd have increased during each of the previous five years (and since 2009, sales have increased a total of 104%).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Cipla Ltd
  Stock Performance Chart for Cipla Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (11/14/2014): 609.20
(Figures in Indian Rupees)
1 Week -6.3%   13 Weeks 2.3%  
4 Weeks 35.8%   52 Weeks 51.2%  
 
Cipla Ltd Key Data:
  Ticker: CIPLA Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2014 Sales 101,003,900,000
(Year Ending Jan 2015).
Employees: 27,562
  Currency: Indian Rupees Market Cap: 489,139,690,684
  Fiscal Yr Ends: March Shares Outstanding: 802,921,357
  Share Type: Ordinary Closely Held Shares: 290,056,172
 
 
Featured Products and Services
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.